Tavilermide ophthalmic solution

tavilermide · Mimetogen Pharmaceuticals USA, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Tavilermide ophthalmic solution, covering 2023-03-09 to 2024-06-10. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Evaluation of Tavilermide Ophthalmic Solution for the Treatment of Dry Eye [Phase 3]